>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
缓激肽在缺血预处理中的作用
作者:王力1 张运生2 刘歧山2 周陵1 张子沪1 
单位:1.南京铁道医学院附属医院,心血管内科,江苏,南京,210009; 2.南京铁道医学院,医学科学研究所,江苏,南京,210009
关键词:缓激肽 B2受体 B1650 缺血预处理 缺血再灌注 大鼠 
分类号:R331.3+1, R541.8+3, R977.6
出版年·卷·期(页码):2000·19·第一期(33-34)
摘要:

目的:研究缓激肽(BK)是否参与了大鼠心肌缺血预处理(IP).方法:观察缺血再灌注组、缺血预处理组、缺血再灌注前给予缓激肽组、缺血再灌注前给予缓激肽及缓激肽B2受体拮抗剂B1650组以及缺血预处理时加B1650组各组缺血复灌前后心功能变化,并且检测复灌末丙二醛(MDA)和超氧化物歧化酶(SOD)的变化.结果:缺血再灌注前给予缓激肽可明显减轻再灌注损伤,使心脏收缩及舒张功能明显高于缺血再灌注组,MDA生成下降,SOD活性增加;加B1650,这种保护作用消失.结论:缓激肽参与缺血预处理心肌保护的作用是通过激活缓激肽B2受体介导的.

Objective  The aim of the present  study was to determine  whether bradykinin has a protective effect during ischemia?reperfusion and involves in ischemic preconditioning in the rat heart.Methods  Acute reversible left main coronary artery occlusion was used.Forty healthy SD rats were randomly divided into five groups:(1)ischemia?reperfusion(IR); (2)ischemic preconditioning (IP); (3)treatment with bradykinin before ischemia( BK+IR); (4) bradykinin treatment combined with pretreatment with bradykinin B  2 receptor antagonist B    1650   before ischemia (BK+BKA+IR); (5)ischemic preconditioning combined with B  2 receptor antagonist B    1650   (BKA+IP). Heart function before and after ischemia?reperfusion were examined.We also measured the content of malondialdehyde(MDA) and superoxide dismutase(SOD) at the end of reperfusion.Results  Bradykinin reduced the injury induced by ischemia?reperfusion,improved the heart function,decreased the MDA production,increased the SOD activity.Pretreatment with bradykinin B  2 receptor antagonist B    1650   completely abolished the effect of bradykinin or ischemic preconditioning.Conclusion  Bradykinin, through B  2 receptors,can protect ischemic myocardium from ischemic injury , and is involved in ischemic preconditioning in our model.

参考文献:

[1] Murry CE, Jennings R B, Reimier K A. Preconditioning with ischemic:a delay of lethal cell injury in ischemic myocardium, 1986
[2] Bouchard J F, Chouinard J, Lamontagne D. Role of kinins in the endothelial protective effect of ischemic preconditioning. 1998(3). doi:10.1038/sj.bjp.0701619
[3] Starkopf J, Bugge E, Ytrehus K. Preischemic bradykinin and ischemic preconditioning, 1997(1)
[4] Wall T M, Sheehy R, Hartman J C. Role of bradykinin in myo~cardial preconditioning, 1994
[5] Martorana P A, Linz W, Schokens B A. Does bradykinin play a role in the cardiac anti ischemic effect of the ACE inhibitors, 1991
[6] Brew E C, Mitchell M B, Rehring T F. Role of bradykinin in cardiac functional protection after global ischemia reperfusion in rat heart, 1995
[7] Yang X P, Liu Y H, Scicli G M. Role of kinins in the cardioprotective effect of preconditioning:study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen deficient rats, 1997  

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 412599 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364